Real-time Intervention for Suicide Risk Reduction

July 30, 2019 updated by: Evan Kleiman, Harvard University
The goal of this study is to provide an initial pilot test of an Ecological Momentary Intervention (EMI) designed the reduce the distress associated with negative emotion among individuals at risk for suicide that pairs content from a smartphone with a wearable physiological monitor. Participants will be 25 suicidal adult inpatients who will complete three brief therapy sessions with a study therapist and then complete exercises associated with the study for the duration of the inpatient period and for 28 days after they leave the hospital.

Study Overview

Detailed Description

The goal of this study is to provide an initial pilot test of an Ecological Momentary Intervention (EMI) designed the reduce the distress associated with negative emotion among individuals at risk for suicide that pairs content from a smartphone with a wearable physiological monitor. Participants will be 25 suicidal adult inpatients who will complete three brief therapy sessions with a study therapist and then complete exercises associated with the study for the duration of the inpatient period and for 28 days after they leave the hospital. During the time they are in the study, participants will be asked to install on their smartphone a mobile application to deliver the therapeutic content and will wear a physiological monitoring device on their wrist (Empatica Embrace) which will monitor objective signals of physiological distress (e.g., skin conductance).

Study Type

Interventional

Enrollment (Anticipated)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02114
        • Recruiting
        • Massachusetts General Hospital
        • Contact:
        • Principal Investigator:
          • Jeff C Huffman, MD
        • Sub-Investigator:
          • Kate H Bentley, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria:

  • A recent suicide attempt or serious suicidal ideation (i.e., ideation with at least 70% intent or a suicide plan with access to lethal means),
  • The ability to speak and write English fluently, access to an internet-capable smartphone (e.g., an iPhone or Android phone)
  • Providing at least one collateral contact in cases where the investigators cannot reach the participant.

Exclusion criteria:

  • The presence of any factor that impairs an individual's ability to comprehend and effectively participate in the study including:
  • An inability to speak or write English fluently
  • The presence of gross cognitive impairment due to florid psychosis, intellectual disability, dementia, or acute intoxication.
  • The presence of extremely agitated or violent behavior.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Ecological Momentary Intervention
This group will receive three intervention prompts and three assessment prompts on their smartphone each day.
Content of this intervention is based on pre-established transdiagnostic protocols for addressing the negative emotion associated with suicidal thoughts and behaviors.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in momentary levels of self-reported distress
Time Frame: Through study completion (duration of inpatient stay + 4 weeks post-discharge)
Assessed via smartphone assessments
Through study completion (duration of inpatient stay + 4 weeks post-discharge)
Change in momentary levels of physiological distress
Time Frame: Through study completion (duration of inpatient stay + 4 weeks post-discharge)
Skin conductance (assessed with wearable device)
Through study completion (duration of inpatient stay + 4 weeks post-discharge)
Change in momentary levels of suicidal thinking
Time Frame: Through study completion (duration of inpatient stay + 4 weeks post-discharge)
Assessed via smartphone assessments
Through study completion (duration of inpatient stay + 4 weeks post-discharge)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Evan Kleiman, Harvard University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 29, 2019

Primary Completion (Anticipated)

March 31, 2020

Study Completion (Anticipated)

July 31, 2020

Study Registration Dates

First Submitted

May 9, 2019

First Submitted That Met QC Criteria

May 13, 2019

First Posted (Actual)

May 15, 2019

Study Record Updates

Last Update Posted (Actual)

August 1, 2019

Last Update Submitted That Met QC Criteria

July 30, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • IRB18-1813
  • R34MH113757-01A1 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data will be shared in accordance with NIH data sharing policies.

IPD Sharing Time Frame

Data will be available within 6 months of the completion of the final participant.

IPD Sharing Access Criteria

Data will be released to the NIMH's data repository and anyone with access to the repository can access these data.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicide, Attempted

Clinical Trials on Ecological momentary intervention

3
Subscribe